H.C. Wainwright Reinstates First Wave BioPharma (FWBI) at Neutral following ImmunogenX deal and capital raise
Tweet Send to a Friend
(Updated - March 25, 2024 6:45 AM EDT)
H.C. Wainwright analyst Yi Chen reinstates coverage on First Wave BioPharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Yi Chen reinstates coverage on First Wave BioPharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
